Concordance between FVC and FEV 6 for identifying chronic airflow obstruction and spirometric restriction in the Burden of Obstructive Lung Disease (BOLD) study
Authors:
Open Access
- 13 July 2025
- journal article
- research article
- Published by BMJ in BMJ Open Respiratory Research
- Vol. 12 (1) , e002355
Abstract
Introduction: We investigated whether the forced expiratory volume in 6 s (FEV 6 ) can be used as a surrogate for the forced vital capacity (FVC). Methods: The Burden of Obstructive Lung Disease is a multinational cohort study. At baseline, data were collected from adults, aged 40 years or older, from 41 sites across 34 countries. Participants from 18 sites were followed-up after a median of 8.3 years. Participants who completed the study core questionnaire and had acceptable post-bronchodilator spirometry were included. We performed receiver operating characteristic analyses to measure the ability of FEV 1 /FEV 6 less than the lower limit of normal (LLN) to correctly classify FEV 1 /FVC less than the LLN, and FEV 6 less than the LLN to correctly classify FVC less than the LLN. We used multilevel regression analyses to assess the association of discordant measurements with respiratory symptoms, quality of life and lung function decline. Results: At baseline, 28 604 participants were included. 53% were female (15 060). 10% (2876) had chronic airflow obstruction for FEV 1 /FVC, compared with 9% (2704) for FEV 1 /FEV 6 . 37% (10 637) had spirometric restriction for FVC, compared with 35% (9978) for FEV 6 . The FEV 1 /FEV 6 had excellent accuracy in identifying FEV 1 /FVC less than the LLN (area under the curve (AUC): 0.90, 95% CI, 0.89 to 0.91, κ coefficient 0.82). The FEV 6 also had excellent agreement in identifying FVC less than the LLN (AUC: 0.95, 95% CI, 0.94 to 0.95, κ coefficient 0.90). Discordant reductions in FEV 1 /FEV 6 (1%, 345) and FEV 6 (1%, 309) were associated with greater odds of having respiratory symptoms and a lower physical quality of life. 3870 participants were followed up. Those with discordant reductions in FEV 1 /FEV 6 and FEV 6 were more likely to have chronic airflow obstruction and spirometric restriction at follow-up. Conclusions: There is strong agreement between the FVC and FEV 6 in the identification of chronic airflow obstruction and spirometric restriction.Keywords
Funding Information
- Medical Research Council (MR/R011192/1)
- Wellcome Trust (085790/Z/08/Z)
This publication has 29 references indexed in Scilit:
- Differences between FEV6, FVC and VC at the diagnosis of obstructive ventilatory defectPulmonology, 2024
- Cohort Profile: Burden of Obstructive Lung Disease (BOLD) studyInternational Journal of Epidemiology, 2023
- Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical StatementAmerican Journal of Respiratory and Critical Care Medicine, 2019
- Clinical Significance of Symptoms in Smokers with Preserved Pulmonary FunctionNew England Journal of Medicine, 2016
- Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2013
- Quality of Spirometry tests performed by 9893 adults in 14 countries: The BOLD StudyRespiratory Medicine, 2011
- The FEV1/FEV6 predicts lung function decline in adult smokersRespiratory Medicine, 2002
- FEV6 is an Acceptable Surrogate for FVC in the Spirometric Diagnosis of Airway Obstruction and RestrictionAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Spirometric Reference Values from a Sample of the General U.S. PopulationAmerican Journal of Respiratory and Critical Care Medicine, 1999
- Cross-Validation of Item Selection and Scoring for the SF-12 Health Survey in Nine CountriesJournal of Clinical Epidemiology, 1998